|
|
|
11.03.26 - 15:12
|
Airbus forscht mit RWTH Aachen an Brennstoffzelle für Regionalflugzeuge (Electrive)
|
|
|
Das vom Bundesministerium für Wirtschaft und Energie geförderte Projekt „GENtwoPRO“ widmet sich der Entwicklung eines skalierbaren Brennstoffzellensystems für Regionalflugzeuge mit bis zu 100 Sitzplätzen. Beteiligt daran sind u.a. der PEM-Lehrstuhl der RWTH Aachen, Airbus und das das Deutsche Zentrum für Luft- und Raumfahrt (DLR)....
|
|
|
11.03.26 - 15:12
|
KeyBanc Flags AeroVironment (AVAV) as Top Iran Conflict Winner (24/7 Wall St.)
|
|
|
KeyBanc Capital Markets trimmed its price target on AeroVironment (NASDAQ:AVAV) to $295 from $330 following the company's fiscal third-quarter 2026 earnings report, while maintaining an Overweight rating on the shares. The cut reflects fallout from a stop-work order on the BADGER SCAR program and contract timing disruptions in the Space, Cyber and Directed Energy segment ... KeyBanc Flags AeroVironment (AVAV) as Top Iran Conflict Winner
The post KeyBanc Flags AeroVironment (AVAV) as Top Iran Conflict Winner appeared first on 24/7 Wall St.....
|
|
|
|
|
|
|
|
|
11.03.26 - 15:00
|
Raute′s Financial Statements and Annual Report for 2025 have been published (Cision)
|
|
|
Raute Corporation, Stock Exchange Release, 11 March 2026 at 4:00 p.m. EET
Raute's Financial Statements and Annual Report for 2025 have been published
Raute Corporation's Financial Statements including the Report of the Board of Directors and the Sustainability Statement, Corporate Governance Statement, Remuneration Report and Annual Report for 2025 have been published today. The reports are available both in English and in Finnish.
In accordance with European Single Electronic Format (ESEF) reporting requirements, Raute publishes the Financial Statements in XHTML format in Finnish....
|
|
|
|
|
|
|
|
|
|
|
|
|
11.03.26 - 14:30
|
Gerresheimer-Aktie: Nimmt das Desaster überhaupt kein Ende? (Sharedeals)
|
|
|
Der Pharmazulieferer Gerresheimer kommt nicht zur Ruhe, die Folge ist, dass die Gerresheimer-Aktie immer tierfer fällt. Gestern fiel sie in der Spitze bis zu -17%. Hintergrund war die Verschiebung des Geschäftsberichtes für 2025. Am Mittwoch erholt sie sich aktuell um +15% und steht bei 19 €. Geht der Absturz weiter? Geschäftsabschluss verschoben Der Konzern teilte […]
The post Gerresheimer-Aktie: Nimmt das Desaster überhaupt kein Ende? first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
|
|
|
|
11.03.26 - 14:09
|
Clearmind Medicine Advances Recruitment for CMND-100 Trial′s Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results (GlobeNewswire EN)
|
|
|
Vancouver, Canada, March 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the continuation of participant enrollment for the third cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD)....
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
